Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP119

22 Mar 2017

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mosquito-borne diseases and control
Share to Transgenic Plants and Applications
Share to Vibrio bacteria research studies

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 28341111
DOI: 10.1016/j.vaccine.2017.03.023

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Generation, characterization and immunogenicity of a novel chimeric recombinant protein based on Plasmodium vivax AMA-1 and MSP119PMID 28341111Read ↗

Comparison of the immunogenic properties of recombinant proteins representing the Plasmodium vivax vaccine candidate MSP119 expressed in distinct bacterial vectorsSemantic proximity Read ↗

Immunogenicity of a recombinant protein containing the Plasmodium vivax vaccine candidate MSP119 and two human CD4+ T-cell epitopes administered to non-human primates (Callithrix jacchus jacchus)Semantic proximity Read ↗

Immunogenicity and In Vivo Efficacy of Recombinant Plasmodium falciparum Merozoite Surface Protein-1 in Aotus MonkeysSemantic proximity Read ↗

A Plasmodium falciparum GLURP–MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodiesSemantic proximity Read ↗

In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response.Semantic proximity Read ↗

Human antibodies to recombinant protein constructs of Plasmodium falciparum Apical Membrane Antigen 1 (AMA1) and their associations with protection from malariaSemantic proximity Read ↗

The Immunogenic and Immunoprotective Activities of Recombinant Chimeric T. gondii Proteins Containing AMA1 Antigen FragmentsSemantic proximity Read ↗

In silico design and validation of a Plasmodium falciparum multi-epitope diagnostic antigen (PfMEDA1) for the diagnosis of falciparum MalariaSemantic proximity Read ↗

Recombinant protein vaccines against the asexual blood-stages of<i>Plasmodium falciparum</i>Semantic proximity Read ↗

Multi-protein chimeric antigens, a novel combined approach for efficiently targeting and blocking the blood stage of <i>Plasmodium falciparum</i>Semantic proximity Read ↗

Apical membrane antigen 1: a malaria vaccine candidate in reviewSemantic proximity Read ↗

Evaluation of Naturally Acquired IgG Antibodies to a Chimeric and Non-Chimeric Recombinant Species of Plasmodium vivax Reticulocyte Binding Protein-1: Lack of Association with HLA-DRB1*/DQB1* in Malaria Exposed Individuals from the Brazilian AmazonSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.